Rise in cases of high blood pressure is responsible for the augmentation of global amlodipine market. Amlodipine helps in scaling down blood pressure by widening and relaxing the blood vessels. This helps in obtaining relief from chest pain as well. The generic version of amlodipine is certified as safe by the regulatory bodies.
The companies operating in amlodipine market are exploring strategies to reach out to the under-developed economies, so as to avail the untapped opportunities over here. They are focusing on propagating the usage of generic almodipine to widen their customer base in these territories. Both – tablets and oral suspension are being promulgated.
Amlodipine is one of the prescription drugs available as a tablet or an oral suspension. The brand name drug is Norvasc. However, it is also available as a generic drug.
Amlodipine is also known as amlodipine besylate. It blocks calcium from making an entry into some arteries and tissues. This makes it simpler for the blood to flow to the heart. If one is consuming amlodipine for chest pain, risk of surgeries and hospitalization gets reduced.
If the doctor recommends stoppage of amlodipine, this drug typically stays in the system for nearly 10 days after the last dose.
Improper dosage of amlodipine may result in the skin turning yellow, which could indicate liver-related problems.
| Attribute | Detail |
|---|---|
| Market Drivers |
|
High blood pressure increases the workload of arteries and heart. If not treated on time, the arteries and heart may fail to function properly. This can, in turn, cause damage to kidneys, heart, and brain. There is also a likelihood of getting heart attacks if high blood pressure is not controlled.
Amlodipine relaxes and broadens blood vessels. It thus lowers the blood pressure and makes it simpler for the heart to pump blood in the body.
Amlodipine also has anti-oxidative and anti-inflammatory properties, which provide vasoprotective effects apart from the BP-lowering advantages.
As per the World Heart Federation, high blood pressure affects close to 1.3 billion individuals worldwide, out of which 10 million people succumb to it every year.
Need to control fatalities out of high blood pressure is thus expanding the amlodipine market size.
Chest pain means an uncomfortable or unpleasant sensation experienced in chest, which is characterized by tightness, pressure, burning, and heaviness. Upper abdomen, shoulder arm, neck, or jaw are likely to get affected by chest pain.
As per the case report by Rosales National Hospital, acute chest pain in youngsters is one of the frequent reasons for consulting the emergency department in the U.S. Furthermore, it is the second most common cause of consultation after trauma and accounts for over 5% of visits to the emergency departments.
As per BMC Emergency Medicine, chest pain affects 20-40% of general population across the globe. If left untreated, lack of blood flow can damage the heart. Complications include arrhythmias and cardiogenic shock.
Amlodipine increases blood supply to the heart, thereby checking the occurrence of chest pain. This drug can be used either alone or in conjunction with the other medicines.
Need to keep chest control under check is thus driving the amlodipine industry opportunities.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
As per the latest amlodipine market analysis, North America held the largest share of amlodipine besylate landscape. The region is expected to continue leading this industry pertaining to Antihypertensive Medication during the forecast period. This is attributed to a sizable population of the U.S. suffering from hypertension.
As per the CDC, 48.1% of the individuals in the U.S. suffer from hypertension or diastolic blood pressure greater than 80 mmHg.
Europe’s noticeable amlodipine market growth is owing to more than 20% of the population of the EU battling hypertension (as stated by the European Commission).
The key players in the amlodipine market are increasing their production capacity of amlodipine, especially after receiving approval from the U.S. FDA for its generic version.
Pfizer Inc., Dr. Reddy’s Laboratories Limited, Cipla Limited, Lupin Limited, Zydus Pharmaceuticals (USA) Inc., Wockhardt, Alkem Laboratories Limited, Oxford Pharmaceuticals, Mylan N.V., Apotex Inc., Sun Pharma are some of the key players covered in the amlodipine industry report.
These companies have been profiled based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.
| Attribute | Detail |
|---|---|
| Market Size in 2023 | US$ 413.0 Mn |
| Market Forecast (Value) in 2034 | US$ 670.3 Mn |
| Growth Rate (CAGR) | 4.4% |
| Forecast Period | 2024-2034 |
| Historical Data Available for | 2020-2022 |
| Quantitative Units | US$ Mn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available Upon Request |
| Pricing | Available Upon Request |
It was valued at US$ 413.0 Mn in 2023
It is projected to advance at a CAGR of 4.4% from 2024 to 2034
Growing prevalence of high blood pressure and need to control chest pain
Hospital pharmacies accounted for the largest share in 2023
North America was the dominant region in 2023
Pfizer Inc., Dr. Reddy’s Laboratories Limited, Cipla Limited, Lupin Limited, Zydus Pharmaceuticals (USA) Inc., Wockhardt, Alkem Laboratories Limited, Oxford Pharmaceuticals, Mylan N.V., Apotex Inc., Sun Pharma, and Others
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Amlodipine Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Amlodipine Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product /Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Amlodipine Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Type, 2020-2034
6.3.1. 2.5 mg
6.3.2. 5 mg
6.3.3. 10 mg
6.4. Market Attractiveness Analysis, by Type
7. Global Amlodipine Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2020-2034
7.3.1. High Blood Pressure
7.3.2. Heart Diseases
7.4. Market Attractiveness Analysis, by Application
8. Global Amlodipine Market Analysis and Forecast, by Distribution Channel
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Distribution Channel, 2020-2034
8.3.1. Hospital Pharmacies
8.3.2. Retail Pharmacies
8.3.3. Online Pharmacies
8.4. Market Attractiveness Analysis, by Distribution Channel
9. Global Amlodipine Market Analysis and Forecast, by Region
9.1. Introduction
9.2. Key Findings/Developments
9.3. Market Value Forecast, by Region, 2020-2034
9.3.1. North America
9.3.2. Europe
9.3.3. Asia Pacific
9.3.4. Latin America
9.3.5. Middle East & Africa
9.4. Market Attractiveness Analysis, by Region
10. North America Amlodipine Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Type, 2020-2034
10.3.1. 2.5 mg
10.3.2. 5 mg
10.3.3. 10 mg
10.4. Market Value Forecast, by Application, 2020-2034
10.4.1. High Blood Pressure
10.4.2. Heart Diseases
10.5. Market Value Forecast, by Distribution Channel, 2020-2034
10.5.1. Hospital Pharmacies
10.5.2. Retail Pharmacies
10.5.3. Online Pharmacies
10.6. Market Value Forecast, by Country, 2020-2034
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Type
10.7.2. By Application
10.7.3. By Distribution Channel
10.7.4. By Country
11. Europe Amlodipine Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Type, 2020-2034
11.3.1. 2.5 mg
11.3.2. 5 mg
11.3.3. 10 mg
11.4. Market Value Forecast, by Application, 2020-2034
11.4.1. High Blood Pressure
11.4.2. Heart Diseases
11.5. Market Value Forecast, by Distribution Channel, 2020-2034
11.5.1. Hospital Pharmacies
11.5.2. Retail Pharmacies
11.5.3. Online Pharmacies
11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Type
11.7.2. By Application
11.7.3. By Distribution Channel
11.7.4. By Country/Sub-region
12. Asia Pacific Amlodipine Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Type, 2020-2034
12.3.1. 2.5 mg
12.3.2. 5 mg
12.3.3. 10 mg
12.4. Market Value Forecast, by Application, 2020-2034
12.4.1. High Blood Pressure
12.4.2. Heart Diseases
12.5. Market Value Forecast, by Distribution Channel, 2020-2034
12.5.1. Hospital Pharmacies
12.5.2. Retail Pharmacies
12.5.3. Online Pharmacies
12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Type
12.7.2. By Application
12.7.3. By Distribution Channel
12.7.4. By Country/Sub-region
13. Latin America Amlodipine Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Type, 2020-2034
13.3.1. 2.5 mg
13.3.2. 5 mg
13.3.3. 10 mg
13.4. Market Value Forecast, by Application, 2020-2034
13.4.1. High Blood Pressure
13.4.2. Heart Diseases
13.5. Market Value Forecast, by Distribution Channel, 2020-2034
13.5.1. Hospital Pharmacies
13.5.2. Retail Pharmacies
13.5.3. Online Pharmacies
13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Type
13.7.2. By Application
13.7.3. By Distribution Channel
13.7.4. By Country/Sub-region
14. Middle East & Africa Amlodipine Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Type, 2020-2034
14.3.1. 2.5 mg
14.3.2. 5 mg
14.3.3. 10 mg
14.4. Market Value Forecast, by Application, 2020-2034
14.4.1. High Blood Pressure
14.4.2. Heart Diseases
14.5. Market Value Forecast, by Distribution Channel, 2020-2034
14.5.1. Hospital Pharmacies
14.5.2. Retail Pharmacies
14.5.3. Online Pharmacies
14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Type
14.7.2. By Application
14.7.3. By Distribution Channel
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2023)
15.3. Company Profiles
15.3.1. Pfizer Inc.
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. Dr. Reddy’s Laboratories Limited
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Cipla Limited
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Lupin Limited
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Zydus Pharmaceuticals (USA) Inc.
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. Wockhardt
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Alkem Laboratories Limited
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. Oxford Pharmaceuticals
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. Mylan N.V.
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. Apotex Inc.
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Financial Overview
15.3.10.5. Strategic Overview
15.3.11. Sun Pharma
15.3.11.1. Company Overview
15.3.11.2. Product Portfolio
15.3.11.3. SWOT Analysis
15.3.11.4. Financial Overview
15.3.11.5. Strategic Overview
15.3.12. Others
15.3.12.1. Company Overview
15.3.12.2. Product Portfolio
15.3.12.3. SWOT Analysis
15.3.12.4. Financial Overview
15.3.12.5. Strategic Overview
List of Tables
Table 01: Global Amlodipine Market Size (US$ Mn) Forecast, by Type, 2020-2034
Table 02: Global Amlodipine Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 03: Global Amlodipine Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034
Table 04: Global Amlodipine Market Size (US$ Mn) Forecast, by Region, 2020-2034
Table 05: North America Amlodipine Market Size (US$ Mn) Forecast, by Country, 2020-2034
Table 06: North America Amlodipine Market Size (US$ Mn) Forecast, by Type, 2020-2034
Table 07: North America Amlodipine Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 08: North America Amlodipine Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034
Table 09: Europe Amlodipine Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 10: Europe Amlodipine Market Size (US$ Mn) Forecast, by Type, 2020-2034
Table 11: Europe Amlodipine Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 12: Europe Amlodipine Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034
Table 13: Asia Pacific Amlodipine Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 14: Asia Pacific Amlodipine Market Size (US$ Mn) Forecast, by Type, 2020-2034
Table 15: Asia Pacific Amlodipine Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 16: Asia Pacific Amlodipine Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034
Table 17: Latin America Amlodipine Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 18: Latin America Amlodipine Market Size (US$ Mn) Forecast, by Type, 2020-2034
Table 19: Latin America Amlodipine Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 20: Latin America Amlodipine Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034
Table 21: Middle East & Africa Amlodipine Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 22: Middle East & Africa Amlodipine Market Size (US$ Mn) Forecast, by Type, 2020-2034
Table 23: Middle East & Africa Amlodipine Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 24: Middle East & Africa Amlodipine Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034
List of Figures
Figure 01: Global Amlodipine Market Size (US$ Mn) and Distribution (%), by Region, 2023 and 2034
Figure 02: Global Amlodipine Market Revenue (US$ Mn), by Type, 2023
Figure 03: Global Amlodipine Market Value Share, by Type, 2023
Figure 04: Global Amlodipine Market Revenue (US$ Mn), by Application, 2023
Figure 05: Global Amlodipine Market Value Share, by Application, 2023
Figure 06: Global Amlodipine Market Revenue (US$ Mn), by Distribution Channel, 2023
Figure 07: Global Amlodipine Market Value Share, by Distribution Channel, 2023
Figure 08: Global Amlodipine Market Value Share, by Region, 2023
Figure 09: Global Amlodipine Market Value (US$ Mn) Forecast, 2020-2034
Figure 10: Global Amlodipine Market Value Share Analysis, by Type, 2023 and 2034
Figure 11: Global Amlodipine Market Attractiveness Analysis, by Region, 2024-2034
Figure 12: Global Amlodipine Market Value Share Analysis, by Application, 2023 and 2034
Figure 13: Global Amlodipine Market Attractiveness Analysis, by Application, 2024-2034
Figure 14: Amlodipine Market Value Share Analysis, by Distribution Channel, 2023 and 2034
Figure 15: Global Amlodipine Market Attractiveness Analysis, by Distribution Channel, 2024-2034
Figure 16: Global Amlodipine Market Value Share Analysis, by Region, 2023 and 2034
Figure 17: Global Amlodipine Market Attractiveness Analysis, by Region, 2024-2034
Figure 18: North America Amlodipine Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 19: North America Amlodipine Market Attractiveness Analysis, by Country, 2024-2034
Figure 20: North America Amlodipine Market Value Share Analysis, by Country, 2023 and 2034
Figure 21: North America Amlodipine Market Value Share Analysis, by Type, 2023 and 2034
Figure 22: North America Amlodipine Market Value Share Analysis, by Application, 2023 and 2034
Figure 23: North America Amlodipine Market Value Share Analysis, by Distribution Channel, 2023 and 2034
Figure 24: North America Amlodipine Market Attractiveness Analysis, by Region, 2024-2034
Figure 25: North America Amlodipine Market Attractiveness Analysis, by Application, 2024-2034
Figure 26:North America Amlodipine Market Attractiveness Analysis, by Distribution Channel, 2024-2034
Figure 27: Europe Amlodipine Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 28: Europe Amlodipine Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 29: Europe Amlodipine Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 30: Europe Amlodipine Market Value Share Analysis, by Type, 2023 and 2034
Figure 31: Europe Amlodipine Market Value Share Analysis, by Application, 2023 and 2034
Figure 32: Europe Amlodipine Market Value Share Analysis, by Distribution Channel, 2023 and 2034
Figure 33: Europe Amlodipine Market Attractiveness Analysis, by Region, 2024-2034
Figure 34: Europe Amlodipine Market Attractiveness Analysis, by Application, 2024-2034
Figure 35: Europe Amlodipine Market Attractiveness Analysis, by Distribution Channel, 2024-2034
Figure 36: Asia Pacific Amlodipine Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 37: Asia Pacific Amlodipine Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 38: Asia Pacific Amlodipine Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 39: Asia Pacific Amlodipine Market Value Share Analysis, by Type, 2023 and 2034
Figure 40: Asia Pacific Amlodipine Market Value Share Analysis, by Application, 2023 and 2034
Figure 41: Asia Pacific Amlodipine Market Value Share Analysis, by Distribution Channel, 2023 and 2034
Figure 42: Asia Pacific Amlodipine Market Attractiveness Analysis, by Region, 2024-2034
Figure 43: Asia Pacific Amlodipine Market Attractiveness Analysis, by Application, 2024-2034
Figure 44: Asia Pacific Amlodipine Market Attractiveness Analysis, by Distribution Channel, 2024-2034
Figure 45: Latin America Amlodipine Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 46: Latin America Amlodipine Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 47: Latin America Amlodipine Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 48: Latin America Amlodipine Market Value Share Analysis, by Type, 2023 and 2034
Figure 49: Latin America Amlodipine Market Value Share Analysis, by Application, 2023 and 2034
Figure 50: Latin America Amlodipine Market Value Share Analysis, by Distribution Channel, 2023 and 2034
Figure 51: Latin America Amlodipine Market Attractiveness Analysis, by Region, 2024-2034
Figure 52: Latin America Amlodipine Market Attractiveness Analysis, by Application, 2024-2034
Figure 53: Latin America Amlodipine Market Attractiveness Analysis, by Distribution Channel, 2024-2034
Figure 54: Middle East & Africa Amlodipine Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 55: Middle East & Africa Amlodipine Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 56: Middle East & Africa Amlodipine Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 57: Middle East & Africa Amlodipine Market Value Share Analysis, by Type, 2023 and 2034
Figure 58: Middle East & Africa Amlodipine Market Value Share Analysis, by Application, 2023 and 2034
Figure 59: Middle East & Africa Amlodipine Market Value Share Analysis, by Distribution Channel, 2023 and 2034
Figure 60: Middle East & Africa Amlodipine Market Attractiveness Analysis, by Region, 2024-2034
Figure 61: Middle East & Africa Amlodipine Market Attractiveness Analysis, by Application, 2024-2034
Figure 62: Middle East & Africa Amlodipine Market Attractiveness Analysis, by Distribution Channel, 2024-2034
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Amlodipine Market
*86 figures and 60 tables includes